文献速递复苏、休克与脓毒症消化、代谢与肾脏急症

急诊发热性尿路感染患者接受丙帕他莫后的血流动力学变化

Hemodynamic changes after propacetamol administration in patients with febrile UTI in the ED.
PubMed 文献 · Am J Emerg Med · 2017-10-31
一句话结论急诊发热性尿路感染患者用丙帕他莫后44.6%出现低血压,菌血症或发热时血压正常者可能持续低血压。

该回顾性研究纳入2015年6月至2016年5月急诊诊断发热性尿路感染并使用丙帕他莫的195例患者,分析用药后血流动力学变化。结果显示87例(44.6%)出现低血压,全体患者收缩压、舒张压和心率均显著下降。低血压组基础收缩压和舒张压高于非低血压组。持续低血压患者基线血压更低、发热时血压未升高且菌血症比例更高。作者认为虽总体预后影响不大,但对菌血症或发热时血压正常者应考虑持续低血压可能。

要点

  • 急诊发热性尿路感染患者使用丙帕他莫后44.6%(87/195)出现低血压。
  • 全体患者用药后收缩压135.06±20.45mmHg vs 117.70±16.41mmHg、舒张压79.74±12.17mmHg vs 69.69±10.96mmHg、心率97.46±17.14 vs 90.72±14.90均显著下降。
  • 低血压组基础收缩压144.4±22.3mmHg vs 非低血压组127.6±15.3mmHg,基础舒张压83.3±12.6mmHg vs 76.9±11.0mmHg更高。
  • 持续低血压患者基线血压更低、发热时血压未升高,且菌血症比例高于短暂低血压患者。
  • 作者认为对菌血症或发热时初始血压正常的患者,应考虑持续低血压的可能。

适用人群与场景

  • 2015年6月至2016年5月急诊就诊、诊断为发热性尿路感染并接受丙帕他莫治疗的患者。

诊断标准与关键阈值

  • 持续低血压定义为需要额外补液或血管升压药的低血压。

红旗征与不能漏的情况

  • 菌血症患者。
  • 发热时初始血压正常者。

研究设计与关键结果

  • 回顾性分析195例急诊发热性尿路感染接受丙帕他莫治疗的患者,87例(44.6%)出现低血压。
  • 全体患者用药后收缩压135.06±20.45mmHg vs 117.70±16.41mmHg、舒张压79.74±12.17mmHg vs 69.69±10.96mmHg、心率97.46±17.14 vs 90.72±14.90均显著下降。
  • 低血压组基础收缩压144.4±22.3mmHg vs 非低血压组127.6±15.3mmHg,基础舒张压83.3±12.6mmHg vs 76.9±11.0mmHg更高。
  • 持续低血压患者基线血压更低、发热时血压未升高,且菌血症比例高于短暂低血压患者。
  • 作者结论认为血流动力学变化对预后影响不大,但对菌血症或发热时初始血压正常者应考虑持续低血压可能。

证据类型、等级与局限

  • 证据类型:回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 急诊对发热性尿路感染患者使用丙帕他莫后应关注血压变化,尤其菌血症或发热时初始血压正常者,作者认为应考虑持续低血压可能。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Clinical studies have indicated that transient hypotension can occur after propacetamol administration. This study aimed to analyze the hemodynamic changes after propacetamol administration in patients visiting the ED due to febrile UTI. We also examined the incidence of propacetamol-induced hypotension and compared the clinical characteristics of patients with persistent hypotension, defined as requiring additional fluids or vasopressors, to those with transient hypotension.

METHODS: A retrospective analysis of the electronic medical records of patients who visited the ED between June 2015 and May 2016, were diagnosed with febrile UTI, and treated with propacetamol, was conducted.

RESULTS: We included 195 patients in this study; of these, 87 (44.6%) showed hypotension. In all patients, significant decreases in systolic blood pressure (SBP; 135.06±20.45mmHg vs 117.70±16.41mmHg), diastolic blood pressure (DBP; 79.74±12.17mmHg vs 69.69±10.96mmHg), and heart rate (97.46±17.14mmHg vs 90.72±14.90mmHg) were observed after propacetamol administration. The basal SBP and DBP were higher in the hypotension than in the non-hypotension group (basal SBP: 144.4±22.3mmHg vs 127.6±15.3mmHg; basal DBP: 83.3±12.6mmHg vs 76.9±11.0mmHg). Patients with persistent hypotension had a lower baseline BP, which was not elevated despite fever, and a higher rate of bacteremia than those with transient hypotension.

CONCLUSIONS: Although febrile UTI patients treated with propacetamol in the ED showed hemodynamic changes, these changes did not have a large effect on their prognosis. However, in patients who showed bacteremia or a normal initial BP despite fever, the possibility of developing persistent hypotension should be considered.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Kang S, Durey A, Suh YJ, et al. Hemodynamic changes after propacetamol administration in patients with febrile UTI in the ED. Am J Emerg Med. 2017. PMID: 29100784. doi:10.1016/j.ajem.2017.10.054

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。